Basic Info
  • Grade: Research grade

    Factory Location: Hangzhou

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe, Australasia,Asia,Middle East,Africa

  • Monthly Production Capacity: hundreds of grams

    Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag

  • Delivery Lead Time: In stock or 2-3 weeks

    Sample Provided: yes

    Payment Terms: T/T

    ATX-GD-59, as a pharmaceutical peptide, is a peptide-based therapy (peptide therapy). The main biological mechanism is to imitate epitopes to inactivate leukocytes that attack the thyroid, and prevent anti-thyroid stimulating hormone receptor (TSHR) stimulating antibodies. The immunological basis that can target Graves' disease is expected to become the first modified and innovative therapy for Graves' disease in 60 years. Clinically, ATX-GD-59 has good safety and tolerability in the treatment of Graves' disease, and it can even have normal thyroid stimulating hormone receptor (TSHR) antibody levels.
Send your message to this supplier
  • From:
  • To:
    Hangzhou Go Top Peptide Biotech Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service